<DOC>
	<DOCNO>NCT00404807</DOCNO>
	<brief_summary>The role continuous positive airway pressure ( CPAP ) cardiac function patient CSA OSA study vary result . Nevertheless , clear whether CPAP treatment respiratory sleep disorder CHF could slow deterioration improve cardiovascular function . In attempt yield insight subject , undertook multicentre study analyze role CPAP therapy ( optimal v sham ) LVEF cardiac measurement patient CHF.Aim . We evaluate randomize multicentre placebo ( sham-CPAP ) control study effect CPAP treatment leave ventricle ejection fraction ( LVEF ) among cardiological related variable .</brief_summary>
	<brief_title>Cardiac Function After CPAP Therapy Patients With Chronic Heart Failure Sleep Apnea . A Multicenter Study</brief_title>
	<detailed_description>From Cardiologist Department eight university hospital CHF patient refer Sleep Units sole condition LVEF &lt; 45 % . After interview clinical exploration , 127 245 fulfilled rigid inclusion exclusion criterion order CHF subject without obvious comorbidity ( see flowchart figure 1 ) . These subject go full ( polysomnography ) PSG . Fifty seven per cent ( n : 73 ) apnea hypopnea index ( AHI ) &gt; 10 . Forty three per cent ( n:54 ) AHI &lt; 10 . Only 17 % patient CSA . The selection inclusion criterion use recruitment follow : 1 ) referral patient chronic heart failure sleep laboratory ; 2 ) diagnosis heart failure least one episode cardiac failure ; 3 ) LVEF le 45 % use radionuclide ventriculography ; 4 ) clinical stability least one month prior inclusion ; 5 ) optimum treatment diuretic and/or beta-blockers and/or digoxin and/or ACE inhibitor accord tolerance 6 ) change treatment one month prior inclusion ; 7 ) Apnea-Hypopnea Index ( AHI ) great 10 measure conventional polysomnography . The exclusion criterion follow : 1 ) patient previous diagnosis OSA expose CPAP therapy . 2 ) uncontrolled arterial hypertension ; 3 ) valvular congenital cardiopathy , unstable angina , acute myocardial infarction cardiac surgery three month prior enrolment ; 4 ) severe somnolence define severe sleepiness situation activity ; 5 ) present past medical history clinically significant renal , liver pulmonary disease ; 6 ) untreated hypothyroidism ; 7 ) clinically significant kyphoscoliosis ; 8 ) morbid obesity body mass index ( BMI ) &gt; 41 Kg/m2 ; 9 ) concomitant use follow drug : morphine , hypnotic sedative , theophylline , acetazolamide home oxygen therapy . Informed write consent obtain subject . This study approve Human Ethics Committee 8 centre . The subject select randomized receive CPAP sham CPAP ( Figure 1 ) . They evaluate baseline ( intervention ) three month follow-up . The assessment perform basis LVEF . In addition , hypertension , subjective daytime sleepiness ( sleepiness scale [ ESS ] ( 17 ) , quality life questionnaire accord Spanish version SF-36 also study ( 18 ) The answer SF-36 codify divide two group , physical ( PCS ) mental ( MCS ) eight subclass ( physical function , physical role , bodily pain , general health , vitality , social function , emotional role , mental health ) . Other measurement : dyspnea use Borg scale ( 19 ) , New York Heart Association scale ( NYHA scale ) , 6-minute walk test ( 20-21 ) . The obstructive group account 83 % patient also study . CPAP sham CPAP compliance record built-in device machine register 4 week end treatment period . After one month treatment , another PSG perform re-assess AHI . All visit register database encrypt website homepage Basque Health Service</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<criteria>1. referral patient chronic heart failure sleep laboratory ; 2. diagnosis heart failure least one episode cardiac failure ; 3 . LVEF le 45 % use radionuclide ventriculography ; 4. clinical stability least one month prior inclusion ; 5. optimum treatment diuretic and/or betablockers and/or digoxin and/or ACE inhibitor accord tolerance 6. change treatment one month prior inclusion ; 7. ApneaHypopnea Index ( AHI ) great 10 measure conventional polysomnography 1. patient previous diagnosis OSA expose CPAP therapy . 2. uncontrolled arterial hypertension ; 3. valvular congenital cardiopathy , unstable angina , acute myocardial infarction cardiac surgery three month prior enrolment ; 4. severe somnolence define severe sleepiness situation activity ; 5. present past medical history clinically significant renal , liver pulmonary disease ; 6. untreated hypothyroidism ; 7. clinically significant kyphoscoliosis ; 8. morbid obesity body mass index ( BMI ) &gt; 41 Kg/m2 ; 9. concomitant use follow drug : morphine , hypnotic sedative , theophylline , acetazolamide home oxygen therapy</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2006</verification_date>
	<keyword>Continuous positive airway pressure</keyword>
	<keyword>cardiovascular disease</keyword>
	<keyword>sleep apnea syndrome</keyword>
	<keyword>sleep breathing disorder</keyword>
	<keyword>sham CPAP</keyword>
</DOC>